RecallDepth
Class II Ongoing

RECOMBINATE, [Antihemophilic Factor (Recombinant)], 5 mL vials, Rx Only, Takeda Pharmaceuticals USA, Cambridge, MA 02142, NDC: 00944-2843-01

This recall is currently active, issued August 13, 2025. It was issued by Cardinal Health Inc..

Company
Cardinal Health Inc.
Recall Initiated
July 30, 2025
Posted
August 13, 2025
Recall Number
D-0573-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
3 units
Firm Location
Dublin, OH, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.

Distribution

Nationwide Within the U.S.

Lot / Code Info

Lot: TRB23802AC, Expires: 03/18/2026; TRA22804AA, Expires: 10/18/2025

More recalls by Cardinal Health Inc.

View all recalls by this company →

Other recent Class II Drug recalls